Latest News and Press Releases

New York, USA, May 12, 2025 (GLOBE NEWSWIRE) -- Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight The blood cancer market...

Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership Allogenica received a €2.5 million grant from the French government's France...

Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests,...

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host...

Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics Market Size, Share & Trends Analysis by Product, Test, End Use, and Region, 2025-2030" report has been added to ...

Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global...

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue to...

Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...

PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...